VolitionRx Limited Shareholders' Equity
VolitionRx Limited (VNRX) had Shareholders' Equity of -$32.16 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent -$32.16M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$31.97M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$34.25M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$34.64M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$32.16M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$31.97M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | -$34.25M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | -$34.64M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$31.82M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$27.77M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$24.91M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$21.50M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$21.81M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$15.61M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | -$7.80M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$2.04M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $5.84M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$2.34M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | -$2.57M 10-K · filed 2024-03-25 | -$3.13M 10-K · filed 2023-03-15 |
| 2022-09-30 | $2.84M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $4.08M 10-Q · filed 2022-11-14 | $4.47M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $10.81M 10-Q · filed 2022-11-14 | $11.12M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $17.72M 10-K · filed 2023-03-15 | |
| 2021-09-30 | $21.18M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $26.63M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $31.16M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $16.29M 10-K · filed 2023-03-15 | |
| 2020-09-30 | $18.96M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $18.66M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $9.19M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $14.20M 10-K · filed 2022-03-30 | |
| 2019-09-30 | $17.80M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $16.38M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $15.11M 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $12.14M 10-K · filed 2021-03-22 | |
| 2018-09-30 | $15.11M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $10.05M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $14.01M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $9.96M 10-K · filed 2020-02-20 | |
| 2017-09-30 | $13.39M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $16.58M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $18.49M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $21.18M 10-K · filed 2019-03-13 | |
| 2016-09-30 | $11.81M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $14.33M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $16.91M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $6.04M 10-K · filed 2018-03-01 | |
| 2015-09-30 | $7.14M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $9.41M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $11.08M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $368.18K 10-K · filed 2017-03-10 | |
| 2014-09-30 | -$4.10M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | -$532.35K 10-Q · filed 2014-08-01 | |
| 2014-03-31 | -$1.66M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $680.67K 10-K · filed 2016-03-11 | |
| 2013-09-30 | $391.24K 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $678.59K 10-Q · filed 2013-07-29 | |
| 2013-03-31 | $691.03K 10-Q · filed 2013-05-06 | |
| 2012-12-31 | $833.79K 10-K · filed 2015-03-18 | |
| 2012-09-30 | $1.12M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $1.21M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $970.39K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $1.09M 10-K · filed 2014-03-28 | |
| 2010-12-31 | -$230.93K 10-KT/A · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |